INTERNATIONAL WORKSHOP ON INNOVATIVE TREATMENT STRATEGIES FOR INFECTIOUS DISEASES 2020

Drug development for infectious diseases (IDs) has revolutionized the way how modern society combats some of the biggest threats to global health. Science and technology are continually advancing treatment options for IDs to provide drugs with improved potency, novel modes of action, new formulations and favorable delivery systems. In the recent years we have been witnessing the emergence of long-acting drug formulations and monoclonal antibodies in the ID arena. Their irrefutable potential in prophylaxis and treatment, both for individual patients and for public health, has already been demonstrated for HIV and influenza. While these new advances are groundbreaking for the clinical management of the diseases they have been developed for, their translation to other IDs is often limited due to insufficient cross-disciplinary information exchange. The International Workshop on Innovative Treatment Strategies for Infectious Diseases aims to bridge this knowledge gap by bringing together world leaders in different areas of infectiology.

FORMAT

This workshop will consist of several state-of-the-art invited lectures,  roundtable  discussions, clinical case presentations and  debates. The  program  will  be  designed to allow for maximum discussion and interaction between  expert faculty and delegates. Panel  discussions  and  Q&A  sessions  are  designed  to  foster  spirited and lively discussions on provocative scientific topics that address knowledge gaps in clinical care.

The Workshop will be topped off with a workshop dinner and social events to allow for the perfect opportunity to engage in more informal discussion among attendees.

MEETING OBJECTIVES

The main goal of this Workshop is to provide a platform for discussion on the latest research in the field of new anti-infectious disease agents and their relevance to routine clinical practice.

This Workshop aims to catalyze the clinical research on these ID agents across the different disease areas. In doing so, this will advance the field by optimizing treatment strategies for ID patients.

LEARNING OBJECTIVES

After participating in this unique translational workshop, delegates will be able to:

  • Define the rationale of using mAbs and LADs to combat infectious diseases;

  • Summarize the process of identification, optimization and development of new anti-infectious disease agents;

  • Summarize the latest developments in the field of anti-infectious disease agents and their relevance for patients and public health;

  • Identify the challenges and opportunities in using anti-infectious disease agents in clinical practice;

  • Discuss the importance of anti-infectious disease agents and the way forward in research and clinical practice.

WHO SHOULD ATTEND

  • ID clinicians and other healthcare providers (HCPs) caring for ID patients who will benefit from more knowledge on the latest insights into the research and use of innovative anti-infectious disease agents in clinical practice;

  • HCPs involved in the research and application of new anti-infectious disease agents.

CONTACT US 

 

+31 30 230 7142

PROJECT MANAGER

SAM JACKSON